Co-Diagnostics Inc
OTC:CODX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Co-Diagnostics Inc
OTC:CODX
|
US |
|
Orbis Se
F:OBS
|
DE |
|
S
|
Smart Concrete PCL
SET:SMART
|
TH |
|
Replimune Group Inc
NASDAQ:REPL
|
US |
|
C
|
Classic Filaments Ltd
BSE:540310
|
IN |
|
L
|
Lansen Pharmaceutical Holdings Ltd
F:1LP
|
CN |
|
A
|
Alseres Pharmaceuticals Inc
OTC:ALSE
|
US |
|
F
|
Flexdeal SIMFE SA
ELI:FLEXD
|
PT |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CODX's stock price target?
Not Available
CODX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Co-Diagnostics Inc?
Projected CAGR
120%
Over the last 10 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 8 years is 120%.
What is the Gross Profit forecast for Co-Diagnostics Inc?
Projected CAGR
123%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 45%. The projected CAGR for the next 8 years is 123%.